Atreca has not released the MOA of it's drug ATRC-
Post# of 148294
(Total Views: 674)
Posted On: 02/25/2020 5:47:55 AM
Atreca has not released the MOA of it's drug ATRC-101. What we do know is that it's a immunoglobulin G, subclass 1 (IgG1) antibody. Nothing new, there's 19 drugs of that class already approved by the FDA. Plenty of side effects and can develop resistance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649311/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649311/
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼